Ebos Group (NZSE:EBO) Change In Receivables : NZ$0 Mil (TTM As of Dec. 2024)

View and export this data going back to 1960. Start your Free Trial

What is Ebos Group Change In Receivables?

Ebos Group's change in receivables for the quarter that ended in Dec. 2024 was NZ$0 Mil. It means Ebos Group's Accounts Receivable stayed the same from Jun. 2024 to Dec. 2024 .

Ebos Group's change in receivables for the fiscal year that ended in Jun. 2024 was NZ$0 Mil. It means Ebos Group's Accounts Receivable stayed the same from Jun. 2023 to Jun. 2024 .

Ebos Group's Accounts Receivable for the quarter that ended in Dec. 2024 was NZ$1,572 Mil.

Days Sales Outstanding measures of the average number of days that a company takes to collect revenue after a sale has been made. It is a financial ratio that illustrates how well a company's Accounts Receivable are being managed. Ebos Group's Days Sales Outstanding for the six months ended in Dec. 2024 was 43.37.

In Ben Graham's calculation of liquidation value, Apple Inc's Accounts Receivable are only considered to be worth 75% of book value. Ebos Group's liquidation value for the six months ended in Dec. 2024 was NZ$-2,733 Mil.

Ebos Group Change In Receivables Historical Data

The historical data trend for Ebos Group's Change In Receivables can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Ebos Group Change In Receivables Chart

Ebos Group Annual Data

Trend

Jun15

Jun16

Jun17

Jun18

Jun19

Jun20

Jun21

Jun22

Jun23

Jun24

Change In Receivables

Get a 7-Day Free Trial

Ebos Group Semi-Annual Data
	Jun15	Dec15	Jun16	Dec16	Jun17	Dec17	Jun18	Dec18	Jun19	Dec19	Jun20	Dec20	Jun21	Dec21	Jun22	Dec22	Jun23	Dec23	Jun24	Dec24
Change In Receivables	Get a 7-Day Free Trial															-	-	-	-	-

Ebos Group Change In Receivables Calculation

Change In Accounts Receivable relative to the previous period. It is any increase or decrease in the cash a company is owed by its customers.

Change In Receivables for the trailing twelve months (TTM) ended in Dec. 2024 adds up the semi-annually data reported by the company within the most recent 12 months, which was NZ$0 Mil.

Ebos Group (NZSE:EBO) Change In Receivables Explanation

1. Accounts Receivable are created when a customer has received a product but has not yet paid for that product. Days Sales Outstanding measures of the average number of days that a company takes to collect revenue after a sale has been made. It is a financial ratio that illustrates how well a company's Accounts Receivable are being managed.

Ebos Group's Days Sales Outstanding for the quarter that ended in Dec. 2024 is calculated as:

	Days Sales Outstanding
=	Accounts Receivable	/	Revenue	*	Days in Period
=	1572.467	/	6617.418	*	91
=	43.37

2. In Ben Graham's calculation of liquidation value, Ebos Group's accounts receivable are only considered to be worth 75% of book value:

Ebos Group's liquidation value for the quarter that ended in Dec. 2024 is calculated as:

	Liquidation Value
=	Cash, Cash Equivalents, Marketable Securities	-	Total Liabilities	+	(0.75 * Accounts Receivable)	+	(0.5 * Total Inventories)
=	262.788	-	4863.657	+	0.75 * 1572.467	+	0.5 * 1376.669
=	-2,733

Ebos Group Change In Receivables Related Terms

Thank you for viewing the detailed overview of Ebos Group's Change In Receivables provided by GuruFocus.com. Please click on the following links to see related term pages.

Ebos Group Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Medical Distribution » Ebos Group Ltd (NZSE:EBO) » Definitions » Change In Receivables

Comparable Companies

Traded in Other Exchanges

EBO:Australia

Address

737 Bourke Street, Level 7, Docklands, Melbourne, VIC, AUS, 3008

Website

https://www.ebosgroup.com

Ebos is the largest pharmaceutical wholesaler and distributor across Australia and New Zealand. It services community pharmacies and hospitals, which contribute around 60% and 30% of revenue, respectively. Drug pricing and wholesale margins for PBS medicine are governed by the Australian government's Pharmaceutical Benefits Scheme, or PBS. Wholesale gross margins are capped at 7% for community pharmacy and 10% for hospitals, and ongoing price reform typically results in low-single-digit revenue growth. Aside from pharma distribution, Ebos operates an animal health product wholesale, manufacturing and retail business, as well as undertaking third party logistics services. These segments are smaller contributors to group revenue but due to the unregulated nature are higher-margin operations.

Ebos Group Headlines

No Headlines